Team receives Association of Community Cancer Centers Innovator Award

A team of Vanderbilt employees have received and award for implementing a streamlined follow-up protocol for patients who may not know they have cancer.

Chic Awearness gala to support ovarian cancer research set for Dec. 6

Chic Awearness, a fashion show and fundraiser for ovarian cancer research, returns as an in-person event from 6:30 p.m. to 8:30 p.m. on Monday, Dec. 6.

Koerkenmeier named VICC associate nursing officer

Shifts in neuroendocrine cancer clinical trial design

Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.

VICC’s Mayer departing to take new role with AstraZeneca

Ingrid Mayer, MD, MSCI, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.

Study to evaluate how environment impacts cancer risk

Vanderbilt-Ingram Cancer Center is leading an ambitious project to assess the impact of environmental exposures on cancer risk for people living in Southern states.